CDC’s Advisory Committee for Immunization Practices (ACIP) – June Meeting outcome

On June 24^th, the CDC’s Advisory Committee for Immunization Practices (ACIP) decided on a Category B recommendation in its consideration of the routine use of the serogroup B meningococcal (meningitis B) vaccine in adolescents and college students. This decision allows doctors and families, through individual clinical decision-making, to access the meningitis B vaccine for teens between ages 16 and 23. Though not a broader, Category A recommendation, which would have added the meningitis B vaccine to the standard vaccination schedule, the ACIP’s conclusion makes significant headway in the fight against meningitis B.

Dr. Neal Raisman, a GHLF advocate who lost his son Isaac to meningitis in 2005, provided testimony before the ACIP, urging the Committee to approve the meningitis B vaccine for routine clinical use.

You can read his powerful testimony here